RE: RE: END OF AUGUST IS NEAR..........
"None of these secondary endpoints had sufficient patient populations to demonstrate statistically significant differences; nevertheless the trends are considered by management to be encouraging. Analysis of the trial results is ongoing and all calculations are subject to validation in the final report which is expected to be completed by the end of August. "
What if the end of August re-iterates the lack of statistical significance? Which is more likely than not....
"Notice how the bashers shut themselves up when i mentioned for them to go the TTH board since they have the commercialization rights to NTX-265?"
ARE YOU SURE ABOUT THIS?
Note: I am still holding some shares of sss but I am realistic as to our chances....slim.
The phase IIb crushed the company....simple as that.....a complete turn around now would be a pleasant surprise.